AbbVie

AbbVie Recent News

Barron's Picks And Pans: AbbVie, Crocs, RealReal, Roku And More
Barron's Picks And Pans: Conagra, JPMorgan, L Brands, Weight Watchers And More
Bulls & Bears Of The Week: AT&T, Facebook, GE, Microsoft And More
Barron's Picks And Pans: AT&T, Starbucks, State Street, Verizon And More
Benzinga's Bulls & Bears Of The Week: AbbVie, Netflix, Philip Morris, Wells Fargo And More
Benzinga's Insider Buys Of The Week: AbbVie, Energen, NuStar And More
Benzinga's Bulls & Bears Of The Week: AbbVie, Lululemon, Netflix, Snap And More
Barron's Picks And Pans: Berkshire Hathaway, Microsoft, Time Warner And More
Benzinga's Weekly Bulls & Bears: AbbVie, Kinder Morgan, Paypal, Starbucks, Wynn And More
Barron's Roundtable: A Big Basket Of Bargains For 2018
Morgan Stanley Expects Galapagos Shares To Rise 10%
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Big Biotech In The Earnings Spotlight
Facebook And Amazon: More Earnings From The FANG Stocks
Chrysler And Ford Earnings: Following In GM's Footsteps?
AbbVie's Venclexta Receives Accelerated Approval From FDA, Stock Ticks Higher
AbbVie Falling After Q4 Report, 2016 Guidance Affirmation
Barron's 2016 Roundtable Part 2: Lots Of Savvy Investment Ideas
LifeSci Capital's Andrew McDonald On How To Invest In Booming Biotech
Barron's Recap: This Man Made, Lost And Made A Fortune Investing In Russia
Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Record Highs
#PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints
Markets Rebound After Getting Crushed Intraday, Still Close Lower